本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

羅氏控股

44.91
+0.24000.54%
盤後44.910.00000.00%16:13 EDT
成交量:150.84萬
成交額:6,784.21萬
市值:2,861.22億
市盈率:28.96
高:45.21
開:44.55
低:44.50
收:44.67
52周最高:45.94
52周最低:34.10
股本:63.71億
流通股本:63.71億
量比:1.11
換手率:0.02%
股息:1.53
股息率:3.40%
每股收益(TTM):1.55
每股收益(LYR):2.14
淨資產收益率:31.32%
總資產收益率:13.30%
市淨率:7.92
市盈率(LYR):21.02

資料載入中...

公司資料

公司名字:
羅氏控股
交易所:
OTCQX
成立時間:
1896
員工人數:
103249
公司地址:
Grenzacherstrasse 124,Basel,Basel-Stadt,Switzerland
郵編:
4070
傳真:
41 61 691 00 14
簡介:
Roche Holding AG engages in the prescription pharmaceuticals and diagnostics businesses in Switzerland, Germany, and internationally. It offers pharmaceutical products for treating anemia, cancer, cardiovascular, central nervous system, dermatology, hepatitis B and C, HIV/AIDS, inflammatory and autoimmune, intensive care medicine, leukemia, lymphoma, metabolic disorders, ophthalmology, respiratory disorders, rheumatoid arthritis, skin cancer, and transplantation. The company also offers in vitro diagnostics solutions for indications, such as cardiology, hematology, blood donor screening, coagulation, infectious disease, gynecology, oncology, and women's health. In addition, it supplies diagnostic instruments, reagents, consumables, and test kits for use in the diverse research market. Further, the company discovers, develops, and delivers gene therapies. Roche Holding AG has collaboration with Gilead Sciences, Inc. for COVID-19. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.